Tom Lemberg

Tom Lemberg is the founder and CEO of Curebase. Tom has grown the company from 0 to 125 people and raised $59M in funding. Prior to Curebase, Tom worked at Syapse for 2 years leading product management efforts in EMR integration, clinical trial matching engine, tumor board decision support software, and point-of-care solutions for research coordinators and nurses at major community oncology centers around the U.S. Tom also worked closely to deploy Syapse software platform to major oncology centers. Before Syapse, Tom was a software development engineer at Athenahealth for 1 year and a software development engineer intern at Amazon.com for 4 months. Tom was also a research intern at the Wyss Institute for Biologically Inspired Engineering where they were a data-drive researcher in on Biomarkers for Depression clinical study. In addition, Tom was a teaching fellow at Harvard University for 2 years and 5 months.

Tom Lemberg attended Harvard University, where they earned an A.B. in Computer Science. Theirundergraduate thesis applied Machine Learning to Cancer Epigenomics in breast and lung cancers. Tom also completed a secondary field in Molecular and Cellular Biology. Lemberg then attended Y Combinator, an education program. Tom graduated cum laude from Cranbrook Kingswood Upper School in 2010.